SCHEMBL12158684

SCHEMBL12158684

O=C(/C=C/c1ccccc1)/C=C/C1C=c2ccccc2=CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
MAPT P10636 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP1A2 P05177 3/20 0.53
PLIN1 O60240 2/20 0.53
RECQL P46063 2/20 0.53
PLIN5 Q00G26 2/20 0.53
ABHD5 Q8WTS1 2/20 0.53
CYP2D6 P10635 2/20 0.53
F3 P13726 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 1/20 0.53
HDAC3 O15379 2/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
TNKS O95271 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12158685 0.86 CNR2 (0.44) CYP1A2CYP2D6HCAR2MEN1KMT2A
SCHEMBL12158672 0.73 LMNA (0.54) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL478244 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL22146 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL28181 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL28435740 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL20846 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL20518814 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL20856054 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1
SCHEMBL5347650 0.73 MAPT (1.00) LMNAMAPTCYP2C9CYP1A2PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304581-B2 Method of enantioselective addition to enones NATIONAL TSING HUA UNIVERSITY (TW) 2012-11-06 US disclosed
US-8304581-B2 Method of enantioselective addition to enones NATIONAL TSING HUA UNIVERSITY (TW) 2012-11-06 US disclosed
US-20110282101-A1 METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES NATIONAL TSING HUA UNIVERSITY (TW) 2011-11-17 US disclosed
US-20110282101-A1 METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES NATIONAL TSING HUA UNIVERSITY (TW) 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282101-A1 METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES CPNE4, ENY2, CYP3A4 LMNA 3941/4885MAPT 4541/4885CYP2C9 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.